Diabetes Metab J 44(6):80218 Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS et al (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
While you will start to notice an improvement about 3-6 weeks after treatment, it may take a series of treatments, spaced about 8 weeks apart, to achieve your final result
Oral options If needles are a dealbreaker, orally disintegrating tirzepatide tablets , tirzepatide drops , and oral tirzepatide formats are emerging options
However, the popular GLP-1 medication has been linked to severe health complications in patients, even those who followed instructions closely and consulted their doctors about their side effects